The present invention relates to medical devices, and more particularly to medical devices having hydrophobic surfaces.
Stents are generally tubular devices that are used to support a segment of a blood vessel or other anatomical lumen so as to maintain its patency. Stents are useful, for example, in the treatment of atherosclerotic stenoses in blood vessels, maintaining blood perfusion to downstream tissue after opening of a flow restriction (e.g., via balloon angioplasty). Various types of stent designs have been developed for treating diseases of blood vessels and other tubular structures inside the body. The currently available stents can be classified into two broad categories: affirmatively-expandable and self-expanding.
An affirmatively-expandable stent may be collapsed down on a dilatation catheter while in a radially contracted state, for example, a stent may be collapsed down onto a folded balloon on the end of a balloon dilatation catheter. The stent maintains this collapsed configuration until it is expanded by the dilatation catheter. For example, when the stent has been properly positioned within the lumen, the dilatation catheter may be actuated (e.g., by inflating a balloon within the stent to an appropriate size), expanding the stent to the desired diameter. The catheter is then returned to a contracted state (e.g., by balloon deflation), and the catheter is withdrawn, leaving the expanded stent in place within the lumen. The stent typically remains in its expanded state because of the plastic deformation that was imparted to its structural elements during expansion.
An affirmatively-expandable stent has many attractive attributes. For example, its diameter and outward force against the vessel wall can be adjusted, for instance, by controlling the inflation pressure of the balloon. Affirmatively-expandable stents, however, can also present certain disadvantages. For example, one disadvantage of certain stent designs is that there is some degree of elastic recoil after expansion. Such elastic recoil usually means that there is a reduction in diameter after the balloon is deflated. The degree of reduction in diameter is related, for example, to material selection, structural design, and degree of inward force from the vessel wall. Balloon-expandable stents are known that employ ratcheting or latching means for retaining the expanded configuration. For one example of such a stent, see, e.g., Pub. No. U.S. 2004/0093076 to White et al.
According to an aspect of the invention, medical devices are provided, which have at least two superhydrophobic surface regions which engage one another when the medical device is deployed in vivo.
An advantage of such devices is that the engaged superhydrophobic surface regions help maintain the device in an as-deployed state.
These and other aspects, embodiments and advantages of the present invention will become immediately apparent to those of ordinary skill in the art upon review of the Detailed Description and any claims to follow.
According to an aspect of the present invention, medical devices are provided which have two or more superhydrophobic surface regions (sometimes referred to as superhydrophobic surfaces) which engage one another in vivo.
For example, in some embodiments, stents are provided, which have at least first and second superhydrophobic surface regions which engage one another upon expansion of the stent in vivo. Stents for use in the present invention include vascular stents (e.g., coronary vascular stents, peripheral vascular stents, cerebral stents, etc.), urinary stents (e.g., urethral stents, ureteral stents, etc.), tracheal stents and gastrointestinal stents (e.g., esophageal stents, biliary stents, enteral stents, colorectal stents, etc.), among others.
For purposes of the present invention, a superhydrophobic surface region is one that displays dynamic (receding and/or advancing) water contact angles of 145° or above (e.g., ranging from 145° to 150° to 155° to 160° to 165° to 170° to 175° to 180°). In particularly beneficial embodiments, both the receding and the advancing water contact angles are 145° or above.
The Wilhelmy plate technique is a suitable technique for measuring the dynamic contact angles for various surfaces, including the superhydrophobic surfaces that are formed in conjunction with the present invention. This technique is performed with a solid sample, typically a rectangular plate or some other regular shape such as a cube, round rod, square rod, tube, etc. To the extent that the medical device of interest is not of sufficiently regular geometry to allow its surface to be tested directly using this technique, a sample of regular geometry, which is provided with a surface using the same materials and processes used to provide the medical device surface, may be tested so as to infer the dynamic contact angles of the device.
The Wilhelmy plate technique is performed using a tensiometer. The solid sample is immersed into and withdrawn out of a liquid (i.e., water) while simultaneously measuring the force acting on the solid sample. Advancing and receding contact angles can then be determined from the obtained force curve using well known calculations. The advancing contact angle is the contact angle that is measured as the sample is immersed in the liquid, whereas the receding contact angle is the contact angle that is measured as the sample is removed from the liquid.
Certain plants in nature, including the lotus leaf, exhibit the unusual wetting characteristic of superhydrophobicity. The lotus leaf accomplishes this effect through the use of a surface topography that presents two different length scales to the outside environment. The surface of the lotus leaf, for example, is textured with 3-10 micron-sized hills and valleys that are decorated with nanometer-size particles of a hydrophobic wax-like material. It has been suggested that the hills and valleys ensure that the surface contact area available to water is very low, whereas the hydrophobic nanoparticles prevent penetration of water into the valleys. Whatever the exact mechanism, the net result is that water does not wet the surface and therefore forms nearly spherical water droplets. See, e.g., Pub. No. U.S. 2006/0029808 to Zhai et al.
A typical way of enhancing the hydrophobicity of an object is to employ surface materials with low surface energy, such as fluorocarbon polymers. However, such materials do not ordinarily provide superhydrophobic water contact angles (fluorocarbon polymers ordinarily exhibiting water contact angles that are only as great as about 120° or so). Nevertheless, as indicated above, surfaces with substantially greater water contact angles exist in nature. Moreover, man-made surfaces having superhydrophobic water contact angles also been created. In addition to having low surface energy (inherently hydrophobic) materials present, these surfaces generally possess microscale and/or nanoscale surface texturing (see, e.g., the description of the lotus leaf supra and the description of various synthetic superhydrophobic materials infra).
Superhydrophobic surface regions are known to bind together spontaneously in the presence of water. Without wishing to be bound by theory, it has been reported that this behavior is based on very-long-range hydrophobic attractive forces (e.g., up to 3.5 microns), which are due to evaporation, or “cavitation.” Cavitation is a first-order phase transition characterized by a sudden, strong attractive force and by the appearance of a vapor bridge. For further information, see, e.g., S. Singh et al., Nature, 442, 2006, p. 526.
In the present invention, such attractive forces between superhydrophobic surfaces are employed to (reversibly) bind adjacent medical device surfaces, thereby maintaining the position of the surfaces with respect to one another. For example, in the case of an affirmatively-expandable stent, bringing binding two or more surfaces in this fashion can help to offset the effects of elastic recoil after expansion.
Various embodiments of the invention pertain to stents, although as indicated above, the invention is applicable to devices other than stents. In these embodiments, the stent typically comprises a substantially two-dimensional element which has a curvature that forms all or a portion of a tubular structure. For example, a sheet-like element may extend partially or completely around an axis to form a tubular structure or a portion thereof, a ribbon-like element may extend partially or completely around an axis to form a ring-shaped structure or a portion thereof, a ribbon-like element may extend along the length of an axis in the form of a helix, and so forth.
As used herein, a “substantially two-dimensional element” is one whose thickness is much less than its length and its width, with thicknesses typically being less than ⅕ the width and the length, more typically less than 1/10 the width and the length. As indicated above, examples include sheet-like element and ribbon-like elements, among others.
In certain of these embodiments, the medical device may be a stent that comprises a sheet of material that is rolled upon itself, with at least one superhydrophobic surface region positioned on one side and at one end of the of the sheet and at least one superhydrophobic surface region positioned on the opposite side and at the opposite end of the sheet.
For instance,
A perspective view of a stent of this type is shown in
Returning now to
Although the stent shown in
In the embodiment shown in
In accordance with an embodiment of the present invention, a design like that shown in
As indicated above, in addition to being formed using a low surface energy material (e.g., an inherently hydrophobic material), superhydrophobic surfaces typically have an associated surface roughness. Examples of low surface energy materials include fluorocarbon materials (i.e., materials containing molecules having C—F bonds), for instance, fluorocarbon homopolymers and copolymers such as polytetrafluoroethylene (PTFE), fluorinated ethylene propylene (FEP), ethylene tetrafluoroethylene (ETFE), ethylene chloro-trifluoroethylene (ECTFE), perfluoro-alkoxyalkane (PFA), poly(chloro-trifluoro-ethylene) (CTFE), perfluoro-alkoxyalkane (PFA), and poly(vinylidene fluoride) (PVDF), among many others.
Various methods for providing superhydrophobic surface regions are known, several of which are described in Pub No. U.S. 2007/0005024 to Weber et al., which is hereby incorporated by reference.
Such methods include methods in which an inherently hydrophobic surface material (e.g., a fluorocarbon material, such as a fluorocarbon polymer) is textured to render it superhydrophobic (e.g., using laser ablation techniques, plasma etching techniques, or lithographic techniques in which a material is etched through apertures in a patterned mask). The hydrophobic surface material may correspond to a substrate material or to one or more layers disposed over a substrate material.
Such methods further include methods in which one or more layers of hydrophobic material (e.g., a fluorocarbon material, such as a fluorocarbon polymer) is/are provided over a textured surface. The textured surface may correspond, for example, to a textured substrate material or to one or more layers of textured material disposed over a substrate material, for instance, one or more layers that comprise a sol-gel material or a particulate material (e.g., carbon nanotubes). For instance, a fluorocarbon polymer coating may be deposited over a textured surface by chemical vapor deposition or glow discharge deposition.
In some embodiments, layer-by-layer processes (in which multiple layers of alternating charge are deposited over underlying substrates) may be employed to produce superhydrophobic surface regions. For example, the layers of alternating charge may comprise a negatively charged polyelectrolyte-containing layer, a positively charged polyelectrolyte-containing layer, and a charged particle layer. Polyelectrolytes which can confer hydrophobicity include fluorinated polyelectrolytes.
Specific techniques for forming superhydrophobic coatings over underlying substrates are described, for example, in P. Favia et al., “Deposition of super-hydrophobic fluorocarbon coatings in modulated RF glow discharges,” Surface and Coatings Technology, 169-170 (2003) 609-612 (who report deposited coatings with water contact angle values of 150-165°, characterized by a high degree of fluorination and having ribbon-like randomly distributed surface microstructures that have feature sizes on the order of a micron), A. V. Rao et al., “Comparative studies on the surface chemical modification of silica aerogels based on various organosilane compounds of the type RnSiX4-n,” Journal of Non-Crystalline Solids 350 (2004) 216-223 (who report chemically modified hydrophobic silica aerogels with contact angles as high as 175°), K. K. S. Lau et al., “Superhydrophobic Carbon Nanotube Forests” Nanoletters 3, 1701 (2003) (who report a vertically aligned carbon nanotube “forest,” covered by a thin, conformal polytetrafluoroethylene layer, which displays advancing and receding contact angles of 170° and 160°, respectively), L. Zhai et al., “Stable Superhydrophobic Coatings from Polyelectrolyte Multilayers,” Nano Letters, 2004, Vol. 4, No. 7, 1349-53 (who report surfaces having advancing and receding water contact angles in excess of 160°, formed by first creating a honeycomb-like polyelectrolyte multilayer surface having pores on the order of 10 microns, which is subsequently overcoated with a layer of negatively charged 50 nm silica nanoparticles, followed by chemical vapor deposition of a semifluorinated silane layer).
Using techniques such as those above, a wide range of substrate materials may be provided with superhydrophobic surface regions, suitable examples of which may be selected, for example, from the various substrate materials set forth below. It is also noted that certain of the above techniques are particularly well adapted to forming superhydrophobic surfaces over the interior surfaces of substrate materials, including sol-gel layer-by-layer techniques, layer-by-layer techniques, and CVD techniques.
For further information regarding the formation of superhydrophobic surfaces, see, e.g., Pub No. U.S. 2007/0005024 and the references cited therein.
Substrate materials for use in the invention vary widely and may be selected from (a) organic materials (e.g., materials containing 50 wt % or more organic species) such as polymeric materials and (b) inorganic materials (e.g., materials containing 50 wt % or more inorganic species), such as metallic materials (e.g., metals and metal alloys) and non-metallic materials (e.g., including carbon, semiconductors, glasses and ceramics, which may contain various metal- and non-metal-oxides, various metal- and non-metal-nitrides, various metal- and non-metal-carbides, various metal- and non-metal-borides, various metal- and non-metal-phosphates, and various metal- and non-metal-sulfides, among others).
Specific examples of non-metallic inorganic materials may be selected, for example, from materials containing one or more of the following: metal oxides, including aluminum oxides and transition metal oxides (e.g., oxides of titanium, zirconium, hafnium, tantalum, molybdenum, tungsten, rhenium, and iridium); silicon; silicon-based ceramics, such as those containing silicon nitrides, silicon carbides and silicon oxides (sometimes referred to as glass ceramics); calcium phosphate ceramics (e.g., hydroxyapatite); carbon; and carbon-based, ceramic-like materials such as carbon nitrides.
Specific examples of metallic inorganic materials may be selected, for example, from metals (e.g., biostable metals such as gold, platinum, palladium, iridium, osmium, rhodium, titanium, tantalum, tungsten, niobium and ruthenium, and bioresorbable metals such as magnesium and iron), metal alloys comprising iron and chromium (e.g., stainless steels, including platinum-enriched radiopaque stainless steel), niobium alloys, alloys comprising nickel and titanium (e.g., Nitinol), alloys comprising cobalt and chromium, including alloys that comprise cobalt, chromium and iron (e.g., elgiloy alloys), alloys comprising nickel, cobalt and chromium (e.g., MP 35N) and alloys comprising cobalt, chromium, tungsten and nickel (e.g., L605), alloys comprising nickel and chromium (e.g., inconel alloys), and bioabsorbable metal alloys (e.g., alloys of magnesium, zinc or iron), for example, alloys containing two or more of the following: Mg, Zn, Fe, Ce, Ca, Zr and Li, among others.
Examples of polymeric substrate materials include various biostable and bioresorbable polymers known in the medical device art. Examples include those substrate materials described in Pub No. U.S. 2007/0005024.
Although various embodiments of the invention are specifically illustrated and described herein, it will be appreciated that modifications and variations of the present invention are covered by the above teachings without departing from the spirit and intended scope of the invention.
This application claims priority from U.S. provisional application 61/075,549, filed Jun. 25, 2008, which is incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
5306286 | Stack et al. | Apr 1994 | A |
5618299 | Khosravi et al. | Apr 1997 | A |
5700286 | Tartaglia et al. | Dec 1997 | A |
5733328 | Fordenbacher | Mar 1998 | A |
5824038 | Wall et al. | Oct 1998 | A |
6156062 | McGuinness | Dec 2000 | A |
6224626 | Steinke | May 2001 | B1 |
7258731 | D'Urso et al. | Aug 2007 | B2 |
7391018 | Niu et al. | Jun 2008 | B2 |
7722662 | Steinke et al. | May 2010 | B2 |
7763065 | Schmid et al. | Jul 2010 | B2 |
7803574 | Desai et al. | Sep 2010 | B2 |
20010044651 | Steinke et al. | Nov 2001 | A1 |
20040093076 | White et al. | May 2004 | A1 |
20050038498 | Dubrow et al. | Feb 2005 | A1 |
20050113936 | Brustad et al. | May 2005 | A1 |
20050221072 | Dubrow et al. | Oct 2005 | A1 |
20060029808 | Zhai et al. | Feb 2006 | A1 |
20060085063 | Shastri et al. | Apr 2006 | A1 |
20060240218 | Parce | Oct 2006 | A1 |
20070005024 | Weber et al. | Jan 2007 | A1 |
20070067020 | Rea et al. | Mar 2007 | A1 |
20070225800 | Sahatjian et al. | Sep 2007 | A1 |
20080226694 | Gelbart et al. | Sep 2008 | A1 |
20080248263 | Kobrin | Oct 2008 | A1 |
20090124034 | Niu et al. | May 2009 | A1 |
20090281250 | DeSimone et al. | Nov 2009 | A1 |
20100086604 | Stellacci et al. | Apr 2010 | A1 |
20100285972 | Dubrow et al. | Nov 2010 | A1 |
Number | Date | Country |
---|---|---|
1574180 | Sep 2005 | EP |
9853765 | Dec 1998 | WO |
2006045555 | May 2006 | WO |
Number | Date | Country | |
---|---|---|---|
20090326639 A1 | Dec 2009 | US |
Number | Date | Country | |
---|---|---|---|
61075549 | Jun 2008 | US |